PDF《References (1996)》

Castilletti C;

Dianzani F Interferon induction by HIV-1-infected cells: a possible role of sulfatides or related glycolipids. Virology 221: 113-9 (1996) Ansari-Lari MA;

Gibbs RA Expression of human immunode?ciency virus type

1 reverse transcriptase in trans during virion release and after infec- tion. J Virol 70: 3870-5 (1996) References (1996) V-16 DEC

96 Arase N;

Arase H;

Ohki K;

Nishino Y;

Ikuta K;

Onoe K MitogeniceffectofHIV-infectedhumanTcelllinesonmouse B cells mediated by surface immunoglobulin. Clin Exp Immunol 103: 24-9 (1996) Arion D;

Borkow G;

Gu Z;

Wainberg MA;

Parniak MA The K65R mutation confers increased DNA polymerase pro- cessivity to HIV-1 reverse transcriptase. J Biol Chem 271: 19860-4 (1996) Arion D;

Borkow G;

Gu Z;

Wainberg MA;

Parniak MA The K65R mutation confers increased DNA polymerase pro- cessivity to HIV-1 reverse transcriptase. J Biol Chem 271: 19860-4 (1996) Arion D;

Harada R;

Li X;

Wainberg MA;

Parniak MA HIV-1 reverse transcriptase shows no speci?city for the bind- ing of primer tRNA(Lys3). Biochem Biophys Res Commun 225: 839-43 (1996) Arion D;

Harada R;

Li X;

Wainberg MA;

Parniak MA HIV-1 reverse transcriptase shows no speci?city for the bind- ing of primer tRNA(Lys3). Biochem Biophys Res Commun 225: 839-43 (1996) Artenstein AW;

Hegerich PA;

Beyrer C;

Rungruengthanakit K;

Michael NL;

Natpratan C Sequences and phylogenetic analysis of the nef gene from Thai subjects harboring subtype E HIV-1. AIDS Res Hum Retroviruses 12: 557-60 (1996) Arts EJ;

Ghosh M;

Jacques PS;

Ehresmann B;

Le Grice SF RestorationoftRNA3Lys-primed(-)-strandDNAsynthesisto an HIV-1 reverse transcriptase mutant with extended tRNAs. Implications for retroviral replication. J Biol Chem 271: 9054-61 (1996) Arts EJ;

Marois JP;

Gu Z;

Le Grice SF;

Wainberg MA Effects of 3'

-deoxynucleoside 5'

-triphosphate concentra- tions on chain termination by nucleoside analogs during hu- man immunode?ciency virus type

1 reverse transcription of minus-strand strong-stop DNA. J Virol 70: 712-20 (1996) Artzi HB;

Shemesh J;

Zeelon E;

Amit B;

Kleiman L;

Gorecki M;

Panet A Ribonuclease H activity during initiation of reverse tran- scription using tRNA(lys)/RNA primer/template of human immunode?ciency virus. Arch Biochem Biophys 325: 209-16 (1996) Aruoma OI;

Spencer JP;

Rossi R;

Aeschbach R;

Khan A;

Mah- mood N;

Munoz A;

Murcia A;

Butler J;

Halliwell B An evaluation of the antioxidant and antiviral action of ex- tracts of rosemary and Provencal herbs. Food Chem Toxicol 34: 449-56 (1996) Arya SK;

Gallo RC Human immunode?ciency virus (HIV) type 2-mediated in- hibition of HIV type 1: a new approach to gene therapy of HIV-infection. Proc Natl Acad Sci U S A 93: 4486-91 (1996) Arya SK;

Gallo RC Human immunode?ciency virus (HIV) type 2-mediated in- hibition of HIV type 1: a new approach to gene therapy of HIV-infection. Proc Natl Acad Sci U S A 93: 4486-91 (1996) Asante-Appiah E;

Chan WW Synergistic binding of inhibitors to the protease from HIV type 1. Biochem J

315 ( Pt 1): 113-7 (1996) Asch S;

Knowles L;

Rai A;

Jones BE;

Pogoda J;

Barnes PF Relationship of isoniazid resistance to human immunode?c- iency virus infection in patients with tuberculosis [see com- ments] Am J Respir Crit Care Med 153: 1708-10 (1996) Askari FK;

McDonnell WM Antisense-oligonucleotide therapy. N Engl J Med 334: 316-8 (1996) Atkins MC;

Carlin EM;

Emery VC;

Grif?ths PD;

Boag F Fluctuations of HIV load in semen of HIV positive patients with newly acquired sexually transmitted diseases. BMJ 313: 341-2 (1996) Avivi I;